Citius Oncology presented data at the 2026 EORTC-CLTG meeting showing that LYMPHIR (denileukin diftitox-cxdl) improves skin-related and overall quality of life in adults with relapsed or refractory cutaneous T-cell lymphoma (CTCL). Study 302 revealed sustained benefits in patient-reported outcomes, including reduced itching and better emotional and functional well-being among responders. These findings highlight the importance of quality of life in CTCL treatment decisions. Citius Oncology is also collaborating with the Cutaneous Lymphoma Foundation to advance quality of life standards in CTCL care.
Citius Oncology's LYMPHIR data is the subject, here is Pluang's health sector snapshot as of Nov 05, 2026 01:21 WIB: 121 of 150 US health stocks rose, 27 fell. AHCO rose 17.68% with 82% sell orders; LQDA rose 16.23% with 96% sell orders; MDLN rose 15.90% with 54% sell orders. Typical hold times ranged from 4 to 21 days.
Fox Factory Holding Corp. has appointed Troy Henige as its new Chief Technology Officer (CTO) to lead the company's technology vision, strategy, and product roadmap. This new role aims to enhance innovation, connect engineering strengths across the c...
3M Company has reached a historic $7.35 billion settlement to resolve personal injury claims related to exposure to PFAS, toxic chemicals known as "forever chemicals." The settlement covers about 99% of existing claims, potentially benefiting 115,000...
The global e-learning market is projected to grow from $275.9 billion in 2026 to $506.6 billion by 2032, with a CAGR of 10.62% driven by rising internet connectivity, corporate upskilling demands, and government digital education initiatives. North A...
Goldman Sachs Group, Inc. disclosed that it briefly held a combined stake exceeding 3% in Ontex Group NV shares as of October 27, 2026, with 566,115 voting rights and 1,965,157 financial instruments. However, by October 28, 2026, their combined posit...
BNP Paribas announced its monthly declaration of voting rights and shares as of October 31, 2026. The bank reported a total of 1,101,600,607 shares and an equal number of voting rights. This update is part of regulatory compliance under French commer...
